Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ridgeway business plan: let’s take control of NSPX with 65 million share and make some business decisions that run the share price into the dirt. That way can get no investors and both Ridgeway and Inspyr will cease to exist! Yes right!
Cancer therapies are constantly evolving! What was standard of care 10 years ago is now considered outdated. From standard chemotherapy to combination therapies to immunotherapies the advancement is continuous. Targeted therapies for direct individual tumor kill will be therapy of choice soon! No longer Blasting the body with toxic drugs. Targeted therapies limit side effects while enhancing tumor kill. Scientists, Medical investigators and professional Health Care individuals are responsible for this advancement. Individuals like Colin Hislop who meet the challenges of the enormous work ahead and take it on. Obviously, anyone can have a secret life but to think after reading his bio that he is working to perpetrate some penny stock scam bilking investors out of their cash is ludicrous beyond reason!
During his career, Dr. Hislop has been involved in all phases of drug development from IND to Phase 4, and has led numerous US, European, and global regulatory filings, including 4 NDAs.
From the 10-Q Inspyr is currently working to establish a IND (Investigational New Drug) application for the Novel Immuno-ocology Targeting Platform.
Who better to take this therapy thru all phases of development than Colin who obviously has "BEEN THERE DONE THAT"
Important to investors that NSPX has resumed clinical development of the drug platforms. The talking point about curtailed business can no longer be bandied about! However, some other talking point will undoubtedly come up!
If the truth is know about Ridgeway the 65 million shares of NSPX that it owns a large chuck of those shares may be divided between Lowe and Hislop. It's a private company so who knows!
I wouldn't doubt that Chris Lowe and some of his connections at FLG Partners are financial backers of Ridgeway. He got out of NSPX for no reason and they installed a figure head Michael Cain as CEO probably knowing that Ridgeway and Colin Hislop would eventually control NSPX! Lots of behind the scene goings on between Ridgeway and Inspyr? To say that everything is above board is far from what's happening!
The financial backers of Ridgeway are probably well endowed and have 65 million reasons to see a rise in the share price of NSPX. Colin Hislop did not finance the development of RT-AR001. He works for Eiger, Ridgeway office is his house and he has been in business only for the development of the adenosine therapies in a deal worked out with his friend Chris Lowe, former NSPX CEO (they worked together at Anthera and Peninsula). Colin Hislop is undoubtedly the brains behind RT-AR001 but there are some deep pockets associated with Ridgeway that are going to push this therapy forward.
Ridgeway financial backers and associates of Colin Hislop who financed the development of RT-AR001 are probably well endowed and have 65 million shares of NSPX that they would be thrilled with a substantial rise in NSPX share price. Where did Ridgeway get the money to advance the adenosine patents? Colin works for Eiger and the office is his house and he has been in business only a couple of years. It's obvious that Colin is doing the leg work for some others. He may be the brains but there are some big sluggers stepping up behind him!
COVID, Remdesivir, Gilead are not the focus, However what is the focus is the state of the art, cutting edge cancer killing technology microparticle formulation injection for targeting tumor therapies. A growing and boundless advancement in cancer medicine and Inspyr/Ridgeway have developed a potential first in class therapy. Now you can understand why NSPX shut down operations and let Ridgeway and the scientists/financial backers of Ridgeway take over the development of the therapy. Now it is back with Inspyr with Ridgeway in control and a billion shares available for investors who have a keen eye for the future to advance the drug.
Our potential first-in-class immune-oncology lead asset, RT-AR001, an adenosine receptor antagonist, is differentiated by its novel microparticle formulation that allows for better tumor infiltration and enhanced outcomes when administered intra-tumorally.
Note from 10-Q... BACK IN BUSINESS
During February of 2018, we curtailed our operations due to our lack of cash, but upon the cancellation of the Ridgeway license, we are resuming preclinical development.
Back in clinical development of drug platforms. "We have recently began working on developing IND (investigational new drug) approved studies for our adenosine receptor technology platform"
Going all in on RT-AR001 A novel immuno-oncology delivery technology targeting adenosine receptor antagonists for the treatment of cancer!
Didn't take long for Colin to grab the ball and take off with it. The 8-K 10/08 changed the entire scope of Inspyr and this is just the beginning!
bid all you want ... not many sellers!
The focus has been on Inspyr but a little thought about Ridgway and the enhanced drug technology they sold back to Inspyr for 65 milliom shares preferred stock and control of company. It is known that Colin is CEO and pres. But where did they get the funding to do advance studies of adenosine. Who or what entity is backing Ridgeway. He's got a day job at Eiger .. so is it Eiger. He's worked for some big pharma companies so is he getting funds thru them. If NSPX spikes higher that 65 million shares gets prettier with every tick up. Lots of unanswered questions concerning private company Ridgeway that is now in control of NSPX.
There is nothing that is posted on this site that will move the needle one way or the other .. the future of this ticker is in the hands of Colin and Ridgeway's undisclosed backers! It's wait and see time!
The 8-K dated 10/8 told it all. Ridgeway and Colin Hislop is now in control of NSPX. His bio has been posted on this site many times. There is no doubt what is taking place. He WILL move the drug platforms forward. Whether the adenosine technology from L&C or the cancer studies from Genspera he will do all he can to get NDA applications, licenses and or partners. Ridgeway did not take this on to sit on their hands!
All the posts for and/or against this ticker have been recorded daily. It's wait and see time!
Green is good!
Buys below .01 (subs) and sold above .03 while price was heading to .07 made a nice solid return. Some win some lose!
Actually as many as 40% of filers use the extension periodically! Very common!
NSPX no longer uses their lawyers office as the principle executive office. When Ridgeway took control the office address was moved to 2629 Townsgate Road Westlake Village Ca. That is the office listed for James Dabb a preferred stock holder.
Filings have been late before in fact NSPX was behind in filings but have caught everything up and have been very diligent in the SEC reporting. It's a good sign that they are serious about staying current.
Filed extension for 10-Q due today as per SEC rules.
Price means nothing it was at .0015 when it ran to .03+ and .003 when it ran to .07+..not to worry history will repeat itself.
Great minds usually think alike!
Whats really hilarious are some posts prior to 10/8 that predicted sub .003 and RS on the way just days ahead of the ticker running to .0718. Crystal ball must not have been working those days. Entertaining for sure!
Subs mean nothing.. take a peak at historical data 10/8 - -10/15.. the bottomless pit is the lack of knowledge of the price action of this ticker! Wait and see
11/16 is monday.. beware hundreds of million shares are going to hit the market as some presume! YEAH REGHT! NSPX is having a hard time selling the shares they have currently. They need to sell the shares to pay off debt that they just restructured couple of weeks ago.. Ludicrous! Yes there will be shares sold but only to develop drug platforms as Ridgeway/Nspx moves forward with the IP and patents that it owns. Wait and See!
Same history is in place.. runs up and with no follow thru does a slow low volume drift lower until addition something drives it up. It has happened a few time prior and most likely will happen again. Only this time there is a real bio man in charge with some new financing and shares to wheel and deal. So this next run up may be more than a temporary spike. Be there when it goes off. Wait and See.
The March run was hyped..the October run was run by a group the next run will be ??? All useless speculation that accounts for zilch! Wait and see!
Sub penny means nothing... are memories so short that just last month on Oct 8 it was at .003 and a few days later it .0718. Just wait and see!
The assumption that Ridgeway would get involved to issue shares just to pay off debt is ludicrous. The current debt structure is manageable and any new issue may be for continued development of drug platforms. The thought that as of 11/16 hundreds of millions of shares are going to hit the market and be sold just to pay off a debt that was just restructured makes little sense. Additional debt is a real possibility but it would be to finance the development of the drug platforms.
Pitiful volume not a lot of buyers or sellers. path of least resistance is always down when volume dries up
Sub Penny means nothing.. twice in this year the ticker rallied from .0015 to .03+ and .003 to .07+. Not to worry this will run fast once Colin starts reporting his game plan!
Continue to work real hard and burning up a lot of ink to get that sub penny fill before the next chase kicks in. Filing due Monday.. may find some info as to what's going on with Colin and Ridgeway/Inspyr.
Still trying hard to get that sub penny buy entry. Subs to pennies with big volume a traders nirvana!
Very few buyers or sellers.. lowest volume in months! holding up fairly well with some retail buyers and and some throwing in the towel sellers who are not going to wait for the BIG run! They can't wait to make bucks need pennies now!
Al was too expensive Cain was more in line with the salary parameters!
For years investors and/or traders were putting forth real cash thinking that their money was going to be put to good use advancing the IP and drug platforms of NSPX. However, they were blind to the fact that invested and borrowed money was used to fatten the bottom line of a consulting company, a piggy bank for a law firm and cash cow for offshore accounts. A pathetic exercise in corporate governess. With Ridgeway taking control of this company there is at least a chance that development of IP at NSPX may finally come where with the last non-management there were two chances.. no and none.
Probably raised the AS to 1,000,000,000 shares to sell stock to enhance their corporate live style..Yah Right! They raised it to have sufficient shares for investment as Inspyr moves the drug platforms along. It was Lowe and Cain who borrowed money to pay FLG Partners, Silvestre Law and Sabby and not a penny for drug development. Colin won't have any of that.. read the tea leaves!
Correctamundo!! Ridgeway is now in control of Inspyr. They just recently cleaned up some short term financing.. they just recently increased AS for as of yet non specific reasons. You got an "IRON" man at the helm of this newly regenerated ticker.. the patents and IP are now in the hands of this heavy hitter! I guess you could say that none of this matters NOT ..this ticker runs hard on any news.. do you think that Colin is going to be as quiet and lost as the last duo of Lowe and Cain.. I don't think so. This is the best set up it has had in yrs ... exciting happenings are on the way.
Remember the time it went from .003 to .0718.. and of course the time it went from.0015 to .0314.. why would anyone think that this would not happen again especially with Colin at the wheel. Those that think sub pennies is the end all.. THINK AGAIN! Enjoy the weekend!